The launch of the Wegovy pill in the UK has sparked a price war and a biotech race among pharmaceutical companies. There is also debate over access to the pill and potential stigma associated with its use, as well as reports of huge demand for the weight-loss treatment. Additionally, the launch has led to various business moves, including lawsuits and major bids, among pharmaceutical giants.